Business Context and Reporting Period
Company: Harvard Bioscience, Inc. (HBIO)
Filing Type: Form 8-K (Current Report)
Date of Report: August 8, 2023
Reporting Period: This filing announces financial results for the three and six months ended June 30, 2023. The report serves as a notification of a press release (Exhibit 99.1) and a related conference call held on the filing date.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data. The filing explicitly states that the details of revenue, profit, cash flow, margins, debt, and liquidity are contained in the press release furnished as Exhibit 99.1, which is incorporated by reference but not included in the text provided. Therefore, no specific financial values can be extracted from this document alone.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. It only confirms the issuance of results for the periods ended June 30, 2023. Investors must refer to the referenced press release for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: The Company held a conference call at 8:00 AM ET on August 8, 2023, to discuss the results.
Legal Disclaimer: The information in Item 2.02 and Exhibit 99.1 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section, nor is it incorporated by reference in other filings unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are detailed in this text.
Key Facts for Investor Verification
- Verify the specific revenue and net income figures for the three and six months ended June 30, 2023, by reviewing the press release (Exhibit 99.1) referenced in this filing.
- Confirm the details of the conference call held on August 8, 2023, for management's qualitative commentary on the results.
- Note that the financial data in the referenced press release is not legally "filed" under Section 18 of the Exchange Act, which may affect liability standards for the information provided.
- Check the NASDAQ Stock Market for the trading symbol HBIO to monitor stock performance following the announcement.